At Rigel Pharmaceuticals, we are dedicated to improving the lives of patients through the discovery, development, and commercialization of novel small molecule drugs.

In particular, we are focused on immune and hematologic disorders, cancer, and rare diseases. We see great opportunity to help patients who have diseases where few to no approved treatment options exist.